Exact Mass: 523.2066884000001

Exact Mass Matches: 523.2066884000001

Found 500 metabolites which its exact mass value is equals to given mass value 523.2066884000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

deacetylisoipecoside

C25H33NO11 (523.2053508)

Isoipecoside in which the acetyl group attaced to the nitrogen is replaced by hydrogen.

Deacetylipecoside

C25H33NO11 (523.2053508)

An isoquinoline alkaloid consisting of beta-D-glucose having a (2S,3R,4S)-3-ethenyl-4-{[(1R)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolinium-1-yl]methyl}-5-(methoxycarbonyl)-3,4-dihydro-2H-pyran-2-yl group attached at the anomeric centre.

3-(N-Maleimidopropionyl)biocytin

2-[3-(2,5-Dioxopyrrol-1-yl)propanoylamino]-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoic acid

C23H33N5O7S (523.2100588000001)

Pralnacasan

N-{4-[(2-ethoxy-5-oxooxolan-3-yl)carbamoyl]-6,10-dioxo-hexahydro-1H-pyridazino[1,2-a][1,2]diazepin-7-yl}isoquinoline-1-carboxamide

C26H29N5O7 (523.2066884000001)

Phe Asp Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C22H33N7O8 (523.2390498000001)

Cys Gly Asp Val Met

C19H33N5O8S2 (523.1770458000001)

Tyr Arg Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]propanamido]butanedioic acid

C22H33N7O8 (523.2390498000001)

N-(3-Maleimidopropionyl)biocytin

(2S)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]hexanoic acid

C23H33N5O7S (523.2100588000001)

Gln Val Tyr Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C23H33N5O9 (523.2278168)

Gly Pro Val Asp His

C22H33N7O8 (523.2390498000001)

C29H25N5O5 (523.18556)

COPPER(II) 3,5-DIISOPROPYLSALICYLATE HYDRATE

C26H36CuO7 (523.1756895999999)

Pralnacasan

C26H29N5O7 (523.2066884000001)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

Ibiglustat L-malate

C24H30FN3O7S (523.1788402)

C471 - Enzyme Inhibitor Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat L-Malic acid can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].

VX-740;Hmr 3480

C26H29N5O7 (523.2066884000001)

N-[4-[[5-[5-hydroxy-4-oxo-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]phenyl]acetamide

C31H29N3O5 (523.2107104)

4-[(2S,3R,4S,5R,6S)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]-8-ethyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one

C29H33NO8 (523.2206058)

Asp-Phe-Asp-Gln

(4s,5r,6s)-5-ethenyl-4-{[(1s)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

(4s,5r,6s)-5-ethenyl-4-{[(1s)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C25H33NO11 (523.2053508)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-3-carboxy-1-hydroxypropylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-3-carboxy-1-hydroxypropylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

C22H29N5O10 (523.1914334)

(4s,5r,6s)-5-ethenyl-4-{[(1r)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

(4s,5r,6s)-5-ethenyl-4-{[(1r)-7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C25H33NO11 (523.2053508)

[(5as,6s,7ar,8r,9s,11ar)-9-(acetyloxy)-6-hydroxy-5a,8,11a-trimethyl-1-oxo-3-(pyridin-3-yl)-6,7,7a,9,10,11-hexahydro-2,5-dioxatetraphen-8-yl]methyl acetate

C29H33NO8 (523.2206058)